Prevent Breast Cancer
To fund ground-breaking research into the prediction and prevention of breast cancer. Our four pillars of research are gene research, improved screening & early diagnosis, preventative drugs and diet & lifestyle. Our overall aim is to make breast cancer a preventable disease for our future generations.
Objects
The advancement of health by the prevention of breast cancer for the public benefit worldwide but in particular in the United Kingdom by: - i. Funding research into the causes, prevention, detection and early diagnosis of breast cancer and that the results of the research are promoted and published for the public benefit;ii. Participating in, facilitating or supporting national and international research and development to overcome health inequalities in all aspects of breast cancer prevention among UK ethnic and cultural groups and to disseminate and share output from such programmes to improve breast cancer outcomes for these communities; iii. Informing, raising awareness, so that the public can learn and educate themselves by producing, disseminating and promoting important public health messages about breast cancer risks, symptoms, detection and treatment; iv. Supporting and raising awareness of technological and all other scientific, best practice and diagnostic advancements in breast screening including but not, limited to the support for the National Breast Imaging Academy; v. Providing pastoral services to support patients and their families affected by breast cancer, including but not limited to patient welcoming, orientation, break out spaces and refreshments at the breast screening unit; vi. Advancing all aspects of breast cancer prediction, detection, risk reduction, management, prevention and diagnosis; and vii. Advancing such other aspects of breast cancer prevention as medical and technological advances may recognise and develop in the future, as the trustees in their absolute discretion may determine.
Financial health, per its FY2025 accounts
The accounts state that total income grew by 47% to £2,169,572, resulting in a net income of £643,321. Per the trustees' report, free reserves total £609,202, which equates to over eight months of core operating costs, exceeding the stated policy target of six to nine months. The charity holds significant restricted reserves of £1,553,828, primarily for the National Breast Imaging Academy.
What the accounts disclose
“During the year payroll services were provided free of charge by Sheppards Chartered Accountants, a company in which Charles Levine (Trustee until November 2024) is a Director. The estimated value of such services is £2,800 (2024: £2,800) and therefore an equivalent amount has been included within gifts in kind.” — page 82
“During the year invoices to the value of £5,168 (2024: £5,168) were paid to Gunnercooke Solicitors. This firm is considered a related party as Joe Glass (a Partner until 31 March 2025 at Gunnercooke Solicitors) is married to Pam Glass and is also the Company Secretary.” — page 82
“During the year payroll services were provided free of charge by Sheppards Chartered Accountants, a company in which Charles Levine (Trustee until November 2024) is a Director. The estimated value of such services is £2,800 (2024: £2,800) and therefore an equivalent amount has been included within gifts in kind.” — page 82
“During the year invoices to the value of £5,168 (2024: £5,168) were paid to Gunnercooke Solicitors. This firm is considered a related party as Joe Glass (a Partner until 31 March 2025 at Gunnercooke Solicitors) is married to Pam Glass and is also the Company Secretary.” — page 82
“During the year payroll services were provided free of charge by Sheppards Chartered Accountants, a company in which Charles Levine (Trustee until November 2024) is a Director. The estimated value of such services is £2,800 (2024: £2,800) and therefore an equivalent amount has been included within gifts in kind.” — page 82
“During the year invoices to the value of £5,168 (2024: £5,168) were paid to Gunnercooke Solicitors. This firm is considered a related party as Joe Glass (a Partner until 31 March 2025 at Gunnercooke Solicitors) is married to Pam Glass and is also the Company Secretary.” — page 82
Policies the charity declares
- Bullying and harassment policy and procedures
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
- Volunteer management
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/03/2025
- Volunteers: 50
- Employees paid over £60,000: 1 (£60,001–£70,000: 1)
- Has a trading subsidiary
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/03/2024
- Volunteers: 50
- Employees paid over £60,000: 1 (£60,001–£70,000: 1)
- Trustee benefits, answered Yes to: any trustee benefit; payments to trustees for services to the charity
- Has a trading subsidiary
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 31/03/2023
- Volunteers: 50
- Employees paid over £60,000: 1 (£60,001–£70,000: 1)
- Trustee benefits, answered Yes to: any trustee benefit; payments to trustees for services to the charity
- Has a trading subsidiary
- Grant-making is its main activity
Leadership, per the charity’s website
- Lester Barr MBE — Honorary President
Funders the charity credits
- Bioderma
- Prevent Cancer UK
- The Tim Bacon Foundation
Structured financials (annual return, FY ending 31/03/2025)
Trustees
- Eamonn O'Neal OBE DLchair
- CHRISTINE LEE-JONES
- Diana Harris
- Dr MARY WILSON
- Jane Humphris
- LESTER BARR
- Mark Sellers
- PAM GLASS
- Paul Topham
- Sandra Saleh
- Tammy Hopla
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £2.2m | £1.5m |
| 31/03/2024 | £1.5m | £1.6m |
| 31/03/2023 | £1.4m | £1.1m |
| 31/03/2022 | £1.1m | £518k |
| 31/03/2021 | £672k | £439k |
Common questions
Is Prevent Breast Cancer financially healthy?
Per its FY2025 accounts: The accounts state that total income grew by 47% to £2,169,572, resulting in a net income of £643,321. Per the trustees' report, free reserves total £609,202, which equates to over eight months of core operating costs, exceeding the stated policy target of six to nine months. The charity holds significant restricted reserves of £1,553,828, primarily for the National Breast Imaging Academy. Its FY2025 accounts were audited by Alliotts LLP.
Who funds Prevent Breast Cancer?
Funders whose own accounts filings name Prevent Breast Cancer as a grant recipient include DENISE COATES FOUNDATION, ASSOCIATION OF BREAST SURGERY, THE TIM BACON FOUNDATION, THE PENNIES FOUNDATION, THE BEAVERBROOKS CHARITABLE TRUST.
Known funders
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| Trafford Metropolitan Borough Council | 17/06/2017 | £500 | Voluntary Sector Grant to Prevent Breast Cancer Limited |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| DAVID LISTER CHARITABLE TRUST | 2 | £30k |
| THE WILL CHARITABLE TRUST | 2 | £20k |
| SSP FOUNDATION | 2 | £3k |
| THE CHANDRIS FOUNDATION | 2 | £3k |
| THE MICHAEL AND ANNA WIX CHARITABLE TRUST | 2 | £400 |
| OGLESBY CHARITABLE TRUST | 1 | £340k |
| BREAST CANCER NOW | 1 | £300k |
| THE FRANCES AND AUGUSTUS NEWMAN FOUNDATION | 1 | £176k |
Charities like this
- AGAINST BREAST CANCER LIMITED
- BREAST CANCER UK LIMITED
- Blood Cancer UK Research
- WOMEN'S CANCER DETECTION SOCIETY
- BREAST CANCER RESEARCH AID (BCRA)
- BREAST CANCER SUPPORT
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| Prevent Breast Cancer | £2.2m | — | — | unclear | — | no doubt |
| AGAINST BREAST CANCER LIMITED | £1.4m | — | — | above | — | no doubt |
| BREAST CANCER UK LIMITED | £2.1m | — | 0 | above | 17.7% | no doubt |
| Blood Cancer UK Research | £21.1m | — | — | unclear | — | no doubt |
| WOMEN'S CANCER DETECTION SOCIETY | £74k | — | 0 | unclear | 3.2% | no doubt |
| BREAST CANCER RESEARCH AID (BCRA) | £123k | — | 0 | unclear | — | no doubt |